Pediatric Growth Disorders, Gebunden

Klappentext

Advances in pediatric endocrinology are reshaping how clinicians understand, diagnose, and treat short stature, and this volume brings those breakthroughs into sharp focus. Blending foundational science with emerging therapeutic strategies, it offers a comprehensive and clinically actionable guide for practitioners committed to improving growth outcomes in children.

The book moves through a wide spectrum of contemporary issues, beginning with innovative nonhGH therapies and the transformative role of artificial intelligence in growthdisorder management. It challenges longstanding assumptions by deconstructing the category of idiopathic short stature and provides nuanced analysis of the strengths and limitations of growth hormone stimulation testing. Readers are guided through evolving concepts of growth hormone deficiency, the unique growth trajectories of children born small for gestational age, and the expanding therapeutic landscape shaped by longacting growth hormone formulations. Further chapters illuminate the complexities of imprinting disorders and their diagnostic pathways, while also examining the evidencebased use of GnRH analogues and aromatase inhibitors as adjunctive therapies during puberty. Together, these discussions create a cohesive, forwardlooking exploration of the future of growthdisorder care.

Written for pediatric endocrinologists, general pediatricians, fellows, and researchers, Pediatric Growth Disorders: Controversies in Diagnosis and Management provides the scientific depth, diagnostic clarity, and therapeutic insight needed to navigate an era in which precision medicine and technological innovation are redefining what is possible for children with short stature.

Dedicated to the memory of Professor Martin O. Savage, whose words and wisdom will continue to inspire readers for generations to come.